Medx Health Corp V.MDX

Sell the technology or get bought out

[Infidel_]

Time for MDX to pass the technology on to a group who can execute. Probably a private, healthcare focused firm would be the best option to actually get this thing to the market where it can help people and get monetized. Likely the only way for the company to get out of its jam, too. The share structure is gross, the stock price is low and the treasury is empty. After all these years, there has been no real, substantial progress of the type that long-time observers would be forgiven for expecting. If that doesn't happen, I smell a roll back and another financing.

With respect to Agoracom, there are two questions:
- has the share price increased since they were brought on board? 
- has the liquidity increased?

Both appear to be resounding "no".

As far as potential investor awareness, have their been any conferences, webinars, interviews, social media, etc. etc. to get this story out there apart from little trickles here and there? Has Agoracom been arranging such things?

Frankly, I don't think this company has a prayer unless something drastic is done and done soon.

[hopefull]

its very clear that mdx is not listening to these boards or have any interest in driving share price up. What is clear that their silence speaks to their direction. I thought Mike might address share holders concerns and give guidance but that was made clear by Robert that he will not give guidance. I think we are looking down an empty barrel and mdx has no respect for those who have helped them

[JusRob201]

I'm trying to find the most charitable thing you could say about MDX management at this point. Incompetence, lack of initiative or is the market just not interested? For cost of all the advisors, sales partners, Agoracom etc how many actual sales has this amounted to?  The lack of follow-up from Q3 alludes to nothing happening for Q4 and I'm unsure of Von Der Porten's

[Infidel_]

part of the problem i see is that this company doesn't act like a micro cap publicly traded entity that is funded by share issuance. it sees itself as a revenue-generator and has all but ignored the need to get out and promote the STOCK not necessarily the B2B approach of promoting the technology. Of course for stock investors, sales will become increasingly important and the technology is the